Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-1247]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTARY INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 23, 2023. Such persons may also file a written request for a hearing on the application on or before October 23, 2023.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 3, 2023, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616-3466, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
                    ( print page 57132) Controlled substance
Drug
                             code
ScheduleGamma Hydroxybutyric Acid
2010
ITetrahydrocannabinols
7370
IAmphetamine
1100
IILisdexamfetamine
1205
IIMethylphenidate
1724
IIANPP (4-Anilino-N-phenethyl-4-piperidine)
8333
IIPhenylacetone
8501
IICodeine
9050
IIOxycodone
9143
IIHydromorphone
9150
IIHydrocodone
9193
IIMethadone
9250
IIMorphine
9300
IIOripavine
9330
IIThebaine
9333
IIOpium extracts
9610
IIOpium fluid extract
9620
IIOpium tincture
9630
IIOpium, powdered
9639
IIOxymorphone
9652
IINoroxymorphone
9668
IIFentanyl
9801
II
 The company plans to manufacture the listed controlled substances in bulk for conversion to other controlled substances and sales to its customers for dosage form development, clinical trials and use in stability qualification studies. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Claude Redd, Acting Deputy Assistant Administrator.


[FR Doc. 2023-18043 Filed 8-21-23; 8:45 am] BILLING CODE P